Gastrointestinal contrast agent developer E-Z-EM of Westbury, NY, this month appointed David Wills as general manager for its U.K. subsidiary, E-Z-EM Ltd. of London. Wills plans to focus on bolstering the company’s share in the U.K. barium sulfate
Gastrointestinal contrast agent developer E-Z-EM of Westbury, NY, this month appointed David Wills as general manager for its U.K. subsidiary, E-Z-EM Ltd. of London. Wills plans to focus on bolstering the companys share in the U.K. barium sulfate contrast market. He comes to E-Z-EM from Medtronic U.K. Ltd., where he served as business development manager for that firms peripheral vascular division. Wills brings 16 years of medical device sales experience to his new post.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.